Kymera Therapeutics Inc (KYMR) stock news · rev $39.2M
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
This KYMR news page leads with what Kymera Therapeutics Inc filed — not a scraped headline mill.
No cached 8-K sentence for KYMR yet. We will not pad this page with generic market recap.
Latest reported KYMR revenue for 2025-12-31 was $39.2M. Net income was -$311.4M. Revenue was down 16.7% from 2024-12-31 to 2025-12-31. KYMR currently screens at market cap $7.39B.
EDGAR remains the official archive. Lician caches the exhibit so you can read what changed without a wire story.
Not investment advice. For the model open the KYMR stock page; for the tape open the quote page.
KYMR stock news FAQ
What are KYMR's latest revenue and net income?
Latest cached Kymera Therapeutics Inc (KYMR) revenue for Dec 31, 2025 was $39.2M. Net income was -$311.4M. Statements: https://lician.com/financials/kymr
How did KYMR revenue change from the prior cached period?
Cached Kymera Therapeutics Inc (KYMR) revenue was down 16.7% from $47.1M (Dec 31, 2024) to $39.2M (Dec 31, 2025). Statements: https://lician.com/financials/kymr
What is KYMR's market cap?
Kymera Therapeutics Inc (KYMR) market cap is $7.39B on the latest cached fundamentals snapshot.
What kind of company is KYMR?
Kymera Therapeutics Inc (KYMR) is a biotechnology company listed on NASDAQ.
Where is KYMR stock news listed?
Cached stock news for Kymera Therapeutics Inc (KYMR) is listed at https://lician.com/news/kymr. Filings: https://lician.com/sec/kymr
Not investment advice.